Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04301375
Title Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial) (ELPIS)
Acronym ELPIS
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors David Garcia Cinca
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.